Physician profile
Arjun Bobby Sood
NPI 1487097341
$98,524.27
in general payments reported to CMS, 2019-2025
29 companies · $24K in 2025
The $24K reported for 2025 was more than what 97% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,696 · 2020: $3,803 · 2021: $1,192 · 2022: $10K · 2023: $33K · 2024: $25K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $44K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Consulting Fee: $10K · Food and Beverage: $4,882 · Travel and Lodging: $2,687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $43,705.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,350.00 |
| Consulting Fee | $10,121.31 |
| Food and Beverage | $4,881.80 |
| Travel and Lodging | $2,686.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyepoint US, INC. | $28,738.36 | 2021-2023 | |
| Alimera Sciences, INC. | $28,729.58 | 2020-2024 | Iluvien, Yutiq |
| Ani Pharmaceuticals, INC. | $17,533.90 | 2025 | Purified Cortrophin Gel, Yutiq |
| Carl Zeiss Meditec, INC. | $6,785.34 | 2020-2024 | Forum Glaucoma Workplace, Clarus, Retina Workplace |
| Neurotech Pharmaceuticals, INC. | $6,158.81 | 2025 | Encelto |
| Genentech USA, INC. | $3,996.69 | 2020-2025 | Vabysmo, Susvimo |
| Regeneron Pharmaceuticals, INC. | $1,699.07 | 2019-2022 | |
| Abbvie INC. | $878.00 | 2022-2025 | Ozurdex |
| Dutch Ophthalmic, USA | $839.68 | 2024 | Tissueblue, Eva, Combined Machine |
| Carl Zeiss Meditec USA, INC. | $562.70 | 2021-2024 | Lumera 700 |
| Regeneron Healthcare Solutions, INC. | $546.82 | 2021-2025 | Eylea, Eylea Hd |
| Astellas Pharma US INC | $396.12 | 2023-2025 | Izervay |
| Alcon Vision LLC | $375.02 | 2021-2023 | |
| Allergan, INC. | $233.75 | 2021 | |
| Bausch & Lomb Americas INC. | $226.93 | 2022-2025 | Xipere, Stellaris |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apellis Pharmaceuticals, INC. | $134.02 | 2022-2025 | Syfovre |
| Ocular Therapeutix, INC. | $123.11 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $119.55 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $80.68 | 2020-2021 | |
| Sandoz INC. | $66.28 | 2024-2025 | Cimerli |
| Harrow Eye, LLC | $64.38 | 2025 | Iheezo |
| Biogen, INC. | $41.07 | 2022 | |
| Merck Sharp & Dohme LLC | $37.68 | 2019 | |
| Samsara Vision | $31.45 | 2025 | Implantable Miniature Telescope (Imt By Dr. Isaac Lipshitz) |
| Biotissue Holdings INC. | $30.93 | 2023 | |
| Novartis Pharmaceuticals Corporation | $29.46 | 2021-2023 | |
| Amgen INC. | $28.02 | 2025 | Nplate, Vectibix |
| Coherus Oncology, INC. | $19.82 | 2023 | |
| Aerie Pharmaceuticals, INC. | $17.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arjun Sood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.